14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $9.96 $11.82 Friday, 3rd May 2024 FOLD stock ended at $10.40. This is 0.288% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.15% from a day low at $10.36 to a day high of $10.79.
90 days $9.96 $14.03
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
Mar 29, 2023 $11.26 $11.30 $11.13 $11.23 2 115 400
Mar 28, 2023 $11.18 $11.48 $11.07 $11.21 1 944 221
Mar 27, 2023 $11.21 $11.24 $10.95 $11.08 3 791 627
Mar 24, 2023 $11.12 $11.19 $10.84 $11.11 2 084 783
Mar 23, 2023 $11.20 $11.38 $10.95 $11.20 2 135 823
Mar 22, 2023 $11.28 $11.40 $11.04 $11.05 1 516 613
Mar 21, 2023 $11.63 $11.67 $11.29 $11.31 1 397 135
Mar 20, 2023 $11.28 $11.63 $11.18 $11.54 1 639 700
Mar 17, 2023 $11.44 $11.44 $11.16 $11.24 3 035 623
Mar 16, 2023 $11.31 $11.66 $11.22 $11.61 1 815 553
Mar 15, 2023 $11.27 $11.52 $11.21 $11.43 1 771 453
Mar 14, 2023 $11.65 $11.72 $11.39 $11.49 1 849 225
Mar 13, 2023 $11.34 $11.66 $11.34 $11.39 1 721 804
Mar 10, 2023 $11.64 $11.70 $11.21 $11.44 3 293 125
Mar 09, 2023 $11.96 $12.03 $11.59 $11.62 1 847 461
Mar 08, 2023 $12.15 $12.15 $11.74 $11.98 1 230 220
Mar 07, 2023 $12.13 $12.31 $11.94 $12.10 1 516 773
Mar 06, 2023 $12.55 $12.60 $11.97 $12.12 1 959 841
Mar 03, 2023 $12.69 $12.86 $12.51 $12.60 2 320 348
Mar 02, 2023 $13.51 $13.53 $12.55 $12.68 3 317 156
Mar 01, 2023 $12.72 $13.84 $12.58 $13.54 2 809 667
Feb 28, 2023 $13.17 $13.44 $13.12 $13.19 2 408 399
Feb 27, 2023 $13.04 $13.20 $13.01 $13.18 1 197 209
Feb 24, 2023 $12.81 $13.01 $12.79 $12.93 1 565 342
Feb 23, 2023 $13.09 $13.11 $12.88 $13.04 1 503 050
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT